This effect appears to be independent of the enabled production of TNFα after SETI administration, which commonly occurs for IL-6 in obesity-promoted HCC development via the activation of oncogenic transcription factor STAT3 [31]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.